Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Celularity revenue
Celularity's revenue is $21.3 million.
What is Celularity's revenue?
- Celularity's revenue growth from 2020 to 2021 is 49.43%.
- Celularity has 35 employees, and the revenue per employee ratio is $609,571.
- Celularity's peak quarterly revenue was $10.6M in 2021(q3).
- Celularity peak revenue was $21.3M in 2021.
- Celularity annual revenue for 2021 was 21.3M, 49.43% growth from 2020.
On this page
Zippi applies for you, and finds you a job.
Celularity financial information
| CEO | Robert J Hariri |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 35 |
| Date Founded | 2016 |
| Headquarters | Warren, New Jersey |
| Number of Locations | 2 |
| Revenue | $21.3M |
| Net Income | $14,192,000 |
| Gross Proft | $11.7M (2021) |
| EBITDA | ($95.1M) (2021) |
| Tax Rate | -0.0% |
| Total Assets | $401,066,000 |
| Ticker | GXGX |
Celularity jobs you might like
Celularity financing
Celularity received early financing of $40.0M on 2017-09-28.
| Series | Round size | Date |
|---|---|---|
| Equity | $202.7M | 11/2018 |
| Equity | $40M | 09/2017 |
Celularity investors
| Investors | Security type |
|---|---|
| Section 32 | Venture Round - Celularity |
| Celgene | Venture Round - Celularity |
| Tony Robbins | Venture Round - Celularity |
| Bill Maris | Venture Round - Celularity |
| United Therapeutics | Venture Round - Celularity |
| Human Longevity | Venture Round - Celularity |
| Sorrento Therapeutics | Venture Round - Celularity |
Celularity competitors
Celularity's top competitor, Kiniksa Pharmaceuticals, earned an annual revenue of $423.2M.
Celularity's smallest competitor is ONL Therapeutics with revenue of $150.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Soligenix | - | $2.4M | 14 | - |
| Kiniksa Pharmaceuticals | - | $423.2M | 111 | - |
| triusrx.com | - | $27.2M | 50 | - |
| Cerexa Inc. | - | $1.3M | 29 | - |
| ONL Therapeutics | - | $150,000 | 28 | - |
| WindMIL Therapeutics | - | $530,000 | 30 | - |
| Obsidian Therapeutics | - | $1.5M | 75 | - |
| JDP Therapeutics | - | $820,000 | 30 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Celularity, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Celularity. The employee data is based on information from people who have self-reported their past or current employments at Celularity. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Celularity. The data presented on this page does not represent the view of Celularity and its employees or that of Zippia.
Celularity may also be known as or be related to Celularity, Celularity Inc, Celularity Inc. and Celularity, Inc.